Antares Pharma Inc (NASDAQ:ATRS)

2.30
Delayed Data
As of Apr 20
 -0.04 / -1.71%
Today’s Change
1.58
Today|||52-Week Range
4.09
+15.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues12.0M13.4M15.1M14.0M
 
 
 
 
 
Cost of Goods Sold5.7M5.1M8.0M6.5M
 
 
 
 
 
Depreciation And Amortization493.7K477.8K548.7K583.8K
 
 
 
 
 
 
Operating ExpensesGross Income5.8M7.8M6.5M6.9M
 
 
 
 
 
General Expenses10.6M10.5M11.5M11.0M
 
 
 
 
 
Research And Development3.1M3.2M3.3M3.6M
 
 
 
 
 
Total Operating Expenses16.8M16.1M20.0M18.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.8M-2.7M-4.9M-4.0M
 
 
 
 
 
Interest Expense On Debt0.00--625.9K628.9K
 
 
 
Other Expenses29.9K-120.3K119.2K933.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.7M-2.8M-5.5M-3.7M
 
 
 
 
 
Net Income-4.7M-2.8M-5.5M-3.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS155.2M155.9M156.4M156.7M
 
 
 
 
 
Shares To Calculate EPS Diluted155.2M155.9M156.4M156.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03-$0.02-$0.03-$0.02
 
 
 
 
 
EPS Diluted-$0.03-$0.02-$0.03-$0.02